IPI-9119
IPI-9119 is an orally active, selective and irreversible FASN inhibitor with an IC50 of 0.3 nM in vitro biochemical assay. IPI-9119 inhibits tumor growth of castration-resistant prostate cancer (CRPC) xenografts mouse models[1][2].
Product Specifications
CAS Number
1346564-56-4
UNSPSC
12352005
Target
Fatty Acid Synthase (FASN)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ipi-9119.html
Concentration
10mM
Purity
98.91
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)C1=CC=C(N(C(N2N=NN(C3=C(F)C=CC=C3F)C2=O)=O)C(C)C)C(OC4=CC=CC=C4)=C1
Molecular Formula
C24H19F2N5O5
Molecular Weight
495.43
References & Citations
[1]Giorgia Zadra, et al. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2019 Jan 8;116 (2) :631-640.|[2]Erin Broph, et al. Abstract 1891: Pharmacological target validation studies of fatty acid synthase in carcinoma using the potent, selective and orally bioavailable inhibitor IPI-9119.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15192281 1 Vial
Lentiviral mouse Gm10229 shRNA (UAS) - Lentiviral mouse Gm10229 shRNA (UAS) (25)
Sign In for Pricing
View Details 
GTR15116593 1 Vial
Lentiviral mouse Slc34a2 shRNA (UAS) - Lentiviral mouse Slc34a2 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
A02339-3-carrier-free 100 µg/Vial
Anti-EIF3A Antibody Picoband®, Carrier-free
Sign In for Pricing
View Details